EX-99.1 2 dex991.htm PRESS RELEASE Press Release

EXHIBIT 99.1

LOGO

Omega Protein Reports 3 Cents Per Share Second Quarter Profit

HOUSTON, August 7, 2006 – Omega Protein Corporation (NYSE symbol: OME), the nation’s leading producer of Omega-3 fish oil and specialty fish meal products, today reported net income of $630,000 (3 cents a share) for the second quarter of 2006, compared with net income of $659,000 (3 cents a share) for the second quarter of the previous year.

Revenues for the second quarter ended June 30, 2006 were $33.3 million compared with revenues of $27.5 million for the comparable quarter in 2005. Omega Protein recorded operating income of $1.5 million for the 2006 second quarter, versus operating income of $0.8 million for the second quarter of 2005.

For the six months ended June 30, 2006, the Company had revenues of $61.6 million, compared with $51.3 million in revenues for the first six months of 2005. Omega Protein recorded operating income of $4.9 million for the six months ended June 30, 2006, versus operating income of $1.0 million for the comparable period a year earlier. The Company had net income of $3.2 million (13 cents a share) for the six months ended June 30, 2006, compared with net income of $766,000 (3 cents a share) for the six months ended June 30, 2005.

Omega Protein’s second quarter results, as well as the results for the first six months of 2006, reflect increased margins primarily due to higher sales prices received during the current year, partially offset by increased costs of production.

About Omega Protein

Omega Protein Corporation is the nation’s largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward-looking statements include, among others, (1) the possibility that the Company’s estimates and assumptions for its calculation of hurricane losses could be incorrect; (2) the Company’s ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, fish oil yields, adverse weather conditions and disease; (3) the impact of worldwide supply and demand relationships on prices for the Company’s products; (4) Omega Protein’s expectations regarding demand for OmegaPure® proving to be incorrect; and (5) fluctuations in the Company’s quarterly operating results due to the seasonality of the Company’s business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega’s filings with the Securities and Exchange Commission, including its 2005 Annual Report on Form 10K under the headings, “Management’s Discussion and Analysis of Financial Condition” and “Risk Factors.”

 

4


OMEGA PROTEIN CORPORATION

Statement of Operations

(unaudited)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2006     2005     2006     2005  
     (in thousands, except per share amounts)  

Revenues

   $ 33,338     $ 27,510     $ 61,641     $ 51,341  

Cost of sales

     28,002       23,693       49,313       44,468  
                                

Gross profit

     5,336       3,817       12,328       6,873  

Selling, general and administrative expense

     3,641       2,957       6,977       5,735  

Loss resulting from natural disaster

     192       —         433       —    

Loss on disposal of assets

     30       96       29       96  
                                

Operating income

     1,473       764       4,889       1,042  

Interest expense, net

     (353 )     (52 )     (645 )     (175 )

Other income (expense), net

     (104 )     230       (126 )     191  
                                

Income before income taxes

     1,016       942       4,118       1,058  

Provision for income taxes

     386       283       962       292  
                                

Net income

   $ 630     $ 659     $ 3,156     $ 766  
                                

Basic earnings per share

   $ 0.03     $ 0.03     $ 0.13     $ 0.03  
                                

Weighted average common shares outstanding

     25,088       24,968       25,066       24,937  
                                

Diluted earnings per share

   $ 0.02     $ 0.03     $ 0.12     $ 0.03  
                                

Weighted average common shares and common share equivalents outstanding

     26,023       26,307       26,016       26,383  
                                

 

5


OMEGA PROTEIN CORPORATION

CONDENSED BALANCE SHEET

(Unaudited)

 

    

June 30,

2006

  

December 31,

2005

     (in thousands)

ASSETS

     

Current assets

   $ 101,880    $ 98,390

Property and equipment, net

     101,422      93,965

Deferred tax assets, net

     5,397      6,293

Other assets

     2,196      1,579
             

Total assets

   $ 210,895    $ 200,227
             

LIABILITIES AND STOCKHOLDERS’ EQUITY

     

Current liabilities

   $ 27,579    $ 19,270

Long-term debt, less current maturities

     26,454      27,658

Other long-term liabilities

     10,984      10,932

Stockholders’ equity

     145,878      142,367
             

Total liabilities and stockholders’ equity

   $ 210,895    $ 200,227
             

Book value per share outstanding

   $ 5.81    $ 5.69
             

CONTACT:

Investor Relations, (713) 623-0060 OR hq@omegahouston.com

Web site: www.buyomegaprotein.com

# # #

 

6